
DSP Healthcare Fund
NAV
₹51.24
as of 20 Aug 2026
DSP Healthcare Fund is an open-ended Sectoral/ Thematic scheme from DSP Mutual Fund managing ₹3,639 crore (as of 31 Jul 2026). Its Direct-plan NAV is ₹51.24 as of 20 Aug 2026. The expense ratio is 0.65% a year. Managed by Chirag Dagli. This page is factual data only — it carries no rating and no recommendation.
Key facts
- Expense ratio
- 0.65% / yr
- as of 30 Jun 2026
- Fund size
- ₹3,639 crore
- as of 31 Jul 2026
- Exit load
- 0.5%
- SIP available
- Yes
- Launched
- 30 Nov 2018
- ISIN
- INF740KA1LG1
₹100 invested, fund vs category
The category line is the average of the funds in this category, built from NYVO’s own NAV data.
Rebased to 100data to 20 Aug 2026Benchmark: Nifty 500 Healthcare TRI
DSP Healthcare Fund
₹215
+115% on ₹100 over 5.0 yrs
Sectoral/ Thematic average
₹210
+110% on ₹100 over 5.0 yrs
Returns vs category
| Window | Fund | Category avg | Gap |
|---|---|---|---|
| 3 months | 12.60% | 6.78% | +5.82 |
| 6 months | 23.30% | 3.68% | +19.62 |
| 1 year | 16.33% | 6.07% | +10.26 |
| 3 years (CAGR) | 22.23% | 16.01% | +6.22 |
| 5 years (CAGR) | 16.51% | 15.20% | +1.31 |
Category average across 119 funds, as of 21 Aug 2026. Short windows are noise; the 3 and 5-year rows are the record. Past returns do not predict future returns.
A single return number depends on its start date. These are ALL the overlapping holding periods, so the worst case is visible — read that number first.
1-year holding periods
- Worst
- -14.0%
- Median
- 13.9%
- Best
- 60.8%
49 windows over the last 60 months, stepped monthly; 71% ended positive. Worst window began 1 Sept 2021. Windows overlap — this is the range of past start dates, not a probability of anything.
3-year holding periods (per year)
- Worst
- 20.0%
- Median
- 22.7%
- Best
- 28.0%
25 windows over the last 60 months, stepped monthly; 100% ended positive. Worst window began 2 Aug 2021. Windows overlap — this is the range of past start dates, not a probability of anything.
Risk, measured
- Sharpe ratio (3Y)
- 0.95
- Sharpe ratio (5Y)
- 0.68
- Sortino ratio (3Y)
- 1.70 vs category 1.55
- Standard deviation (3Y)
- 14.83%
- Beta (3Y)
- 0.85
- Alpha (3Y)
- 1.00%
- Deepest fall (5Y)
- -18.36%
Distance below its own peak
Every dip below 0 is the fund trading under a previous high — how deep and for how long is what a drawdown feels like.
Deepest fall
-13.1%
Right now
At a peak
Ahead of its benchmark in 53% of months (window: 3y, monthly) — benchmark: Nifty 500 Healthcare TRI, name shown only.
Where the money actually is
Equity
93.3%
Cash
6.7%
Whole-portfolio split, as of 31 Jul 2026.
What it owns
32 positions · top 10 = 61.2%
Market-cap mix
Large 24.6%Mid 13.9%Small 42.6%Other 18.9%
as of 31 Jul 2026
Holdings by sector
Healthcare(9 in top 10)91.3%
- Sun Pharmaceuticals Industries Ltd8.40%
- Ipca Laboratories Ltd8.15%
- Cipla Ltd8.10%
- Sai Life Sciences Ltd7.07%
- Gland Pharma Ltd6.33%
- Apollo Hospitals Enterprise Ltd5.79%
- Globus Medical Inc Class A5.55%
- Alkem Laboratories Ltd4.64%
- Cohance Lifesciences Ltd3.74%
- Financial Services1.1%
Sectors marked ▶ expand to show this fund’s top-10 holdings in that sector. Holdings as of 31 Jul 2026. Portfolio turnover 19.3% vs category 37.3% a year.
Other top holdings
- Treps / Reverse Repo Investments5.92%
The businesses it owns
- P/E (trailing)
- 36.1 vs category 25.8
- P/B
- 4.6 vs category 3.8
- Dividend yield
- 0.6% vs category 1.1%
- Net margin
- 15.1% vs category 15.4%
- Earnings growth
- 5.2%
- Avg market cap
- ₹48,600 crore
Money in, money out
- Net flow, 12 months
- +₹139 cr
- Net flow, 3 months
- +₹79 cr
as of 31 Jul 2026. Flows follow performance more than they predict it.
Quick answers
- What is the NAV of DSP Healthcare Fund?
- ₹51.24 per unit as of 20 Aug 2026 (Direct plan, growth). NAV is declared daily on working days.
- What is the expense ratio of DSP Healthcare Fund?
- 0.65% a year for the Direct plan, as of 30 Jun 2026.
- How large is DSP Healthcare Fund?
- ₹3,639 crore under management as of 31 Jul 2026, in the Sectoral/ Thematic category.
- How risky is DSP Healthcare Fund?
- Its SEBI Riskometer reading is "Very High Risk". One sector, one story. The most-launched shelf on the map, by far.
- What are the 5-year returns of DSP Healthcare Fund?
- 16.51% a year over the last 5 years (Direct plan, CAGR), against a Sectoral/ Thematic average of 15.20%. Past returns do not predict future returns.
- What is the worst 3-year return of DSP Healthcare Fund?
- 20.0% a year — the weakest of 25 overlapping 3-year holding periods, beginning 2 Aug 2021. The median was 22.7% and 100% of those windows ended positive. Windows overlap, so this is the range of past start dates, not a probability.
- Who manages DSP Healthcare Fund?
- Chirag Dagli, managing this fund for 5.7 years.
Where this fund sits
Its shelf, all funds
St · Sectoral / thematic →
One sector, one story. The most-launched shelf on the map, by far.
The money map
How big this shelf is in India →
The whole industry sized by real money, from AMFI’s monthly data.
Side by side
Compare this fund →
Put it next to any other fund — growth, returns, risk and cost in one table.
One bet or two?
Check its overlap →
See whether it owns the same stocks as your other funds.
Other Sectoral/ Thematic funds
- ICICI Prudential India Opportunities Fund₹38,299 crore
- ICICI Prudential Business Cycle Fund₹16,123 crore
- DSP India T.I.G.E.R. Fund₹6,325 crore
- ICICI Prudential US Bluechip Equity Fund₹3,821 crore
- Aditya Birla Sun Life Banking and Financial Services Fund₹3,648 crore
- Kotak Business Cycle Fund₹3,411 crore
- Aditya Birla Sun Life MNC Fund₹3,293 crore
- DSP Natural Resources And New Energy Fund₹2,441 crore
Data: NYVO research systems; each block above states its own as-of date, and blocks with no data for this fund are omitted rather than estimated. NAV updates daily on working days. The benchmark (Nifty 500 Healthcare TRI) is named for reference only; its values are licensed and never shown. This page is factual information about one scheme. It is not investment advice, not a recommendation, and it carries no rating of any kind. Past performance does not predict future returns. Mutual fund investments are subject to market risks; read all scheme related documents carefully.